FDA Grants 510(k) Clearance to Waters Corporation for BD BACTEC FXI Blood Culture System

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to the BD BACTEC FXI blood culture system, a diagnostic tool developed by Waters Corporation. This regulatory approval allows the company to distribute the system for use in clinical settings to identify bloodstream infections.

The BACTEC FXI system automates the process of culturing blood samples to detect the presence of microorganisms. By receiving 510(k) clearance, the device meets the agency’s requirements for safety and effectiveness, confirming that it is substantially equivalent to existing legally marketed blood culture systems. The technology aims to assist laboratory professionals in the rapid detection of pathogens, which provides clinicians with data to inform patient treatment plans. Waters Corporation intends to integrate this system into its existing diagnostic portfolio to expand the availability of infection-screening tools for healthcare providers.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 3, 2026

Author

GOAI